MedPath

Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients

Not Applicable
Withdrawn
Conditions
Infection
Wounds
Interventions
Biological: autologous platelet gel
Registration Number
NCT00672672
Lead Sponsor
University of Nebraska
Brief Summary

This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.

Detailed Description

The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patients undergoing coronary artery bypass grafting surgery

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Any patient who meets criteria and consents to undergo a CABG procedure involving conduit sites and consents to this study.
Exclusion Criteria
  • Any patient, after inclusion, whom is later determined to have had on-going therapy that could influence wound healing such as radiation or chemotherapy, extensive steroid use, or accidental trauma such as burns, etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control (No platelet gel)autologous platelet gelParticipants do not receive platlet gel.
Platelet Gelautologous platelet gelParticipants receive platlet gel.
Primary Outcome Measures
NameTimeMethod
Healing and infection of surgical sites30 days

The surgical sites will be assessed for degree of healing and signs and symptoms of infection on post-op days one and three and during the patients' follow up visits in the clinic.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath